Clinical Trial Update: Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA) for effects on the migrating motor complex under receptor block…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Motility Disorders
• Xerostomia

Drugs mentioned

• NG-monomethyl-L-arginine (L-NMMA) (NG-monomethyl-L-arginine)

Snippet

Sponsor: Uppsala University | Conditions: Gastrointestinal Motility Disorder, Disturbance of Salivary Secretion | Phase 1 | Status: COMPLETED